|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.82 USD | -1.03% |
|
+6.65% | +10.77% |
| 08/05 | Earnings Flash (TSVT) 2SEVENTY BIO Reports Q1 Revenue $12.4M, vs. Street Est of $14.1M | MT |
| 08/05 | Transcript : 2seventy bio, Inc., Q1 2024 Earnings Call, May 08, 2024 |
2seventy bio, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported revenue was USD 100.39 million compared to USD 91.5 million a year ago. Net loss was USD 217.57 million compared to USD 254.15 million a year ago.
Basic loss per share from continuing operations was USD 4.42 compared to USD 7.13 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +10.77% | 25Cr | |
| +33.04% | 4.95TCr | |
| +1.99% | 4.26TCr | |
| +49.11% | 4.25TCr | |
| -4.22% | 2.91TCr | |
| +12.00% | 2.66TCr | |
| -22.67% | 1.86TCr | |
| +8.37% | 1.32TCr | |
| +30.32% | 1.25TCr | |
| +24.00% | 1.21TCr |
2SEVENTY BIO, INC. 